These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7682363)
1. Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. Meiser BM; Wenke K; Thiery J; Wolf S; Devens C; Seidel D; Hammer C; Billingham ME; Reichart B Transplant Proc; 1993 Apr; 25(2):2077-9. PubMed ID: 7682363 [No Abstract] [Full Text] [Related]
2. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A. Regazzi MB; Iacona I; Campana C; Gavazzi A; Viganò M; Perani G Transplant Proc; 1994 Oct; 26(5):2644-5. PubMed ID: 7940825 [No Abstract] [Full Text] [Related]
3. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation. Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960 [No Abstract] [Full Text] [Related]
4. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up]. Wenke K; Thiery J; Meiser B; Arndtz N; Seidel D; Reichart B Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016 [TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model. Meiser BM; Wolf S; Devens C; Wenke K; Thiery J; Kreuzer E; Hammer C; Billingham ME; Reichart B Transplant Proc; 1992 Oct; 24(5):1671-2. PubMed ID: 1384201 [No Abstract] [Full Text] [Related]
6. A new model for heterotopic heart transplantation in rodents: graft atrial septectomy. Steinbrüchel DA; Nielsen B; Salomon S; Kemp E Transplant Proc; 1994 Jun; 26(3):1298-9. PubMed ID: 8029913 [No Abstract] [Full Text] [Related]
7. [Can hyperlipidemia after heart transplantation be optimally and safely treated?]. Wenke K; Thiery J; Arndtz N; Seidel D; Reichart B Helv Chir Acta; 1994 Dec; 60(6):1163-8. PubMed ID: 7875999 [TBL] [Abstract][Full Text] [Related]
8. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration. Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425 [No Abstract] [Full Text] [Related]
9. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. Pappu AS; Bacon SP; Illingworth DR J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170 [TBL] [Abstract][Full Text] [Related]
10. FK 506 inhibits the development of transplant arteriosclerosis. Wu GD; Cramer DV; Chapman FA; Cajulis E; Wang HK; Starzl TE; Makowka L Transplant Proc; 1991 Dec; 23(6):3272-4. PubMed ID: 1721433 [No Abstract] [Full Text] [Related]
11. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus. Sartor G; Katzman P; Eizyk E; Kalén J; Nilsson A; Ugander L; Ursing D Int J Clin Pharmacol Ther; 1995 Jan; 33(1):3-6. PubMed ID: 7711988 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476 [No Abstract] [Full Text] [Related]
13. Comparison of the effect of FK 506 and alpha/beta-T-cell antibody R73 on transplant vascular sclerosis after heterotopic rat heart transplantation. Silber RE; Lange V; Gassel AM; Ulrichs K Transplant Proc; 1998 Jun; 30(4):987-8. PubMed ID: 9636398 [No Abstract] [Full Text] [Related]
14. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins. Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172 [TBL] [Abstract][Full Text] [Related]
15. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model. Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903 [No Abstract] [Full Text] [Related]
17. Efficacy of cyclosporine and angiotensin-converting enzyme inhibitor to inhibit cardiac graft atherosclerosis in the rat. Paul LC; Davidoff A; Benediktsson H Transplant Proc; 1994 Oct; 26(5):2873-4. PubMed ID: 7940907 [No Abstract] [Full Text] [Related]
18. Cardiac graft arteriosclerosis in the rat. Adams DH; Wyner LR; Karnovsky MJ Transplant Proc; 1993 Apr; 25(2):2071-3. PubMed ID: 8470275 [No Abstract] [Full Text] [Related]
19. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques. Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082 [TBL] [Abstract][Full Text] [Related]
20. Bioelectrical tissue resistance in the heterotopic rat heart transplant model. Kuinose M; Tanaka N; Orita K Transplant Proc; 1996 Jun; 28(3):1836-8. PubMed ID: 8658907 [No Abstract] [Full Text] [Related] [Next] [New Search]